Quantitation of cytochrome P450 enzymes CYP1A1/2, 2B11, 2C21 and 3A12) in dog liver microsomes by enzyme-linked immunosorbent assay

Xenobiotica

Volumn 26, Issue 7, 1996, Pages 755-763

  Eguchi, K ^a   Nishibe, Y ^a   Baba, T ^a   Ohno, K ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BETA NAPHTHOFLAVONE; CYTOCHROME P450 ISOENZYME; PHENOBARBITAL; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0029681461     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046746     Document Type: Article

References (27)

1. BANDIERA, S., RYAN, D. E., LEVIN, W., and THOMAS, P. E., 1986, Age- and sex-related expression of cytochrome P450f and P450g in rat liver. Archives of Biochemistry and Biophysics, 248, 658-676.
2. BENSOUSSAN, C., DELAFORGE, M., and MANSUY, D., 1995, Particular ability of cytochromes P450 3A to form inhibitory P450-ion-metabolite complexes upon metabolic oxidation of aminodrugs. Biochemical Pharmacology, 49, 591-602.
3. BURKE, M. D., THOMPSON, S., ELCOMBE, C. R., HALPERT, J., HAAPARANTA, T., and MAYER, R. T., 1985, Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between differrent induced cytochromes P450. Biochemical Pharmacology, 34, 3337-3345.
4. BURKE, M. D., THOMPSON, S., WEAVER, R. J., WOLF, C. R., and MAYER, R. T., 1994, Cytochrome P450 specifications of alkoxyresorufin O-dealkylation in human and rat liver. Biochemical Pharmacology, 48, 923-936.
5. CIACCIO, P. J., and HALPERT, J., 1989, Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450 IIIA (steroid-inducible) gene subfamily. Archives of Biochemistry and Biophysics, 271, 284-299.
6. DAUJAT, M., PICHARD, L., FABRE, I., PINEAU, T., FABRE, G., BONFILS, C., and MAUREL, P., 1991, Induction protocols for cytochrome P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods in Enzymology, 206, 345-353.
7. HALPERT, J. R., GUENGERICH, F. R., BEND, J. R., and CORRELA, M. A., 1994, Selective inhibitors of cytochrome P450. Toxicology and Applied Pharmacology, 125, 163-175.
8. HERRERO, M. E., and CASTELL, J. V., 1994, Quantification of CYP1A1 and 2B1/2 in rat hepatocytes cultured in microwells by immunological methods. Toxicology in Vitro, 8, 1167-1175.
9. KAMINSKY, L. S., FASCO, M. J., and GUENGERICH, F. P., 1981, Production and application of antibodies to rat liver cytochrome P-450. Methods in Enzymology, 74, 262-272.
10. KOMORI, M., SHIMADA, H., MIURA, T., and KAMATAKI, T., 1989, Interspecies homology of liver microsomal cytochrome P-450. A form of dog cytochrome P-450 (P450-D1) crossreactive with antibodies to rat P-450-male. Biochemical Pharmacology, 38, 235-240.
11. LOWRY, O., H., ROSEBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
12. MATSUBARA, T., OTSUBO, S., YOSHIHARA, E., and TOUCHI, A., 1983, Biotransformation of coumarin derivatives (2) oxidative metabolism of 7-alkoxycoumarin by microsomal enzymes and simple assay procedure for 7-alkoxycoumarin O-dealkylase. Japanese Journal of Pharmacology, 33, 41-56.
13. NEDELCHEVA, V., and GUT I., 1994, P450 in the rat and man: methods of investigation, substrate specifications and relevance to cancer. Xenobiotica, 24, 1151-1175.
14. NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., OKUDA, K., and NEBERT, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession number, early trivial names of enzymes and nomenclature. DNA and Cell Biology, 12, 1-51.
15. NISHIBE, Y., and HIRATA, M., 1993, Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes. Xenobiotica, 23, 682-692.
16. NISHIBE, Y., and HIRATA, M., 1995, Induction of cytochrome P450 3A (CYP 3A) by E5110, a non-steroidal anti-inflammatory agent (NSAID), and typical CYP 3A inducers in primary culture of dog hepatocytes. Biological and Pharmaceutical Bulletin, 18, 1142-1144.
17. OHTA, K., MOTOYA, M., KOMORI, M., MIURA, T., KITADA, M., and KAMATAKI, T., 1989, A novel form of cytochrome P-450 in beagle dogs: P-450-D3 is a low spin form of cytochrome P-450 but with catalytic and structural properties similar to P-450d. Biochemical Pharmacology, 38, 91-96.
18. OHTA, K., MOTOYA, M., KOMORI, M., MIURA, T., KITADA, M., NAGAO, M., and KAMATAKI, T., 1990, Interspecies homology of cytochrome P-450: Purification and toxicological significance of a high spin form of cytochrome P-450 (P-450-D2) from liver microsomes of polychlorinated biphenyl (PCB)-treated beagle dogs. Journal of Biopharmaceutical Sciences, 1, 59-71.
19. OMURA, T., and SATO, R., 1964. The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370-2378.
20. PARKE, B. K., and BRECKENRIDGE, A. M., 1981, Clinical implications of enzyme induction and enzyme inhibition. Clinical Pharmacokinetics, 6, 1-24.
21. PESSAYRE, D., DESCATOIRE, V., KONSTANTINOVA MITCHEVA, M. K., WANDSCHEER, J. C., COBERT, B., LEVEL, R., BENHAMOU, J. P., JAOUEN, M., and MANSUY, D., 1981, Self induction by triacetyleandomycin of its own transformation into a metabolic forming a stable 456 nm-absorbing complex with cytochrome P-450. Biochemical Pharmacology, 30, 553-558.
22. PLATT, K. L., MOLITOR, E., DÖHMER, J., DOGRA, S., and OESCH, F., 1989, Genetically engineered V79 chinese hamster cell expression of purified cytochrome P-450 IIB1 monooxygenase activity. Journal of Biochemical Toxicology, 4, 1-6.
23. SAKAMOTO, K., KIRITA, S., BABA, T., NAKAMURA, Y., YAMAZOE, Y., KATO, R., TAKANAKA, A., and MATSUBARA, T., 1995, A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization. Archives of Biochemistry and Biophysics, 319, 372-382.
24. SEIDEL, S. L., SHAWVER, L. K., and SHIRES, T. K., 1984, Detection of phenobarbital-induced cytochrome P450 in rat hepatic microsomes using an enzyme-linked immunosorbent assay. Archives of Biochemistry and Biophysics, 229, 519-531.
25. SHIRAGA, T., IWASAKI, K., NOZAKI, K., TAMURA, T., YAMAZOE, Y., KATO, R., and TAKANAKA, A., 1994, Isolation and characterization of four cytochrome P450 isozymes from untreated and phenobarbital-treated beagle dogs. Biological and Pharmaceutical Bulletin, 17, 22-28.
26. TASSANEEYAKUL, W., BIRKETT, D. J., MCMANUS, M. E., TASSANEEYAKUL, W., VERONESE, M. E., ANDERSON, T., TUKEY, R. H., and MINERS, J. O., 1994, Caffeine metabolism by human hepatic cytochrome P450: contribution of 1A2, 2E1 and 3A isoforms. Biochemical Pharmacology, 47, 1767-1776.
27. VENKATESAN, K., 1992, Pharmacokinetic drug interactions with rifampicin. Clinical Pharmacokinetics, 22, 47-65.